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The 11.6-K protein of human adenovirus 2 (Ad2), which was recently renamed as adenovirus death protein (ADP), is a type III
membrane glycoprotein that ultimately localizes to the nuclear membrane. ADP is encoded in the E3 transcription unit of Ad2 and
migrates as a set of multiple bands in SDS–PAGE with three major forms. The corresponding gene product of adenovirus 5 (Ad5)
has a slightly lower molecular weight and shows the same pattern in SDS–PAGE. We report here the covalent attachment of fatty
acids to cysteine residues of ADP. In the case of Ad5-ADP all three major forms of this protein can be labeled by [3H]palmitic acid,
but not by [3H]myristic acid, whereas only two [3H]palmitic acid-labeled Ad2-ADP species could be detected. The label is sensitive
to treatment with 1 M hydroxylamine at pH 7 and with 20% b-mercaptoethanol indicating that the fatty acids are linked via a
thioester bond. By thin layer chromatography, the vast majority of the incorporated label was identified as palmitic acid. Two
cysteine residues at the boundary between transmembrane domain and cytoplasmic tail which could serve as acceptor sites were
mutated to alanine residues by site-directed mutagenesis of the cloned Ad5-ADP gene. Expression of wild-type Ad5-ADP and the
resulting mutants was performed in HeLa cells using the vaccinia virus T7 expression system. As demonstrated by labeling with
[3H]palmitic acid, only the mutants with one remaining cysteine residue in the cytoplasmic tail were able to incorporate [3H]palmitic
acid, indicating that either could serve as acceptor site. In contrast the double cysteine mutant could not be labeled by [3H]palmitic
acid, clearly demonstrating that cysteines 53 and 54 are required for palmitoylation and probably represent the palmitoylation sites
in Ad5-ADP. © 1998 Academic Press
INTRODUCTION
The early transcription unit 3 (E3) of human subgenus
C adenoviruses (Ad) codes for at least five integral mem-
brane proteins which are mainly involved in counteract-
ing the host immune response (Wold et al., 1995). The
11.6-K of Ad2 is an exception among E3-coded proteins
with defined functions in that it has not been shown so
far to interfere directly with immune mechanisms con-
tributing to antiviral defense. Rather, it apparently facili-
tates the release of progeny virions from the infected
cells by triggering host cell lysis (Tollefson et al.,
1996a,b). The mechanism by which 11.6-K exerts its func-
tion is unknown. Because of the death-promoting effects
of 11.6-K expression in Ad-infected cells, 11.6-K has been
recently renamed adenovirus death protein (ADP, Tollef-
son et al., 1996a). In agreement with its proposed func-
tion at the end of the replicative cycle, ADP is expressed
about 400-fold more abundantly late in infection due to
differential splicing which places the ADP gene initially
transcribed from the E3 promoter under the control of the
strong major late promotor of adenovirus (Tollefson et al.,
1992). Structural features and posttranslational modifica-
tions of ADP described so far indicate that it represents
a type III transmembrane protein that is N-glycosylated
but not phosphorylated (Scaria et al., 1992). These au-
thors also proposed that ADP has additional modifica-
tions, possibly O-glycosylation at multiple sites. The ul-
timate intracellular destination of ADP is the nuclear
membrane, but it is also found in the Golgi complex and
the membrane system of the ER (Scaria et al., 1992).
In the present study we addressed another putative
posttranslational modification of ADP, acylation by
long chain fatty acids. Two main pathways exist
whereby proteins are modified by long chain fatty
acids. Myristic acid is cotranslationally attached N-
terminally by an amide linkage to a glycine residue
immediately following the start methionine (Casey,
1994). In contrast, palmitoylation of membrane pro-
teins occurs posttranslationally mostly at cysteine res-
idues either in the extreme C-terminal portion of the
transmembrane domain or the directly adjacent part of
the cytoplasmic domain. Covalent attachment of fatty
acids to membrane proteins has first been described
for the viral glycoproteins of Sindbis virus and vesic-
ular stomatitis virus (Schmidt et al., 1979; Schmidt and
Schlesinger, 1979). Since then, an increasing number
of viral glycoproteins has been found to be modified by
fatty acids, mainly palmitic acid, including several or-
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tho- and paramyxoviruses (Schmidt, 1989) as well as
retroviruses (Yang et al., 1995; Yang and Compans,
1996) or filoviruses (Funke et al., 1995). Palmitate is
mainly found in thioester linkage to cysteine residues
but has also been reported to be bound via an oxyes-
ter linkage to serine or threonine residues of the
myelin proteolipid protein (PLP; Stoffel et al., 1983),
although subsequent studies suggested that mainly
thioester-linked palmitate is present in PLP (Bizzozero
and Good, 1990).
By the discovery of cellular proteins that are palmitoy-
lated (Schlesinger et al., 1980), a second class of palmi-
toylated proteins has been identified over the recent
years which has no hydrophobic transmembrane domain
and is palmitoylated at N-terminal cysteines. Functions
of palmitoylation of cellular proteins include the regula-
tion of signal transduction, modulation of receptor, and
association of the palmitoylated proteins to membranes
(Eason et al., 1994; Mumby and Muntz, 1995; Cadwal-
lader et al., 1994). For viral proteins, the functional sig-
nificance of palmitoylation is still controversial. It has
been shown to play a role in virus assembly and release
(Gaedigk-Nitschko et al., 1990; Zurcher et al., 1994) as
well as conferring cell type specificity (Jin et al., 1996),
whereas its role for the fusogenic properties of the influ-
enza A HA is still a matter of debate (Veit et al., 1991b;
Naeve and Williams, 1990; Philipp et al., 1995). In the
present study we have analyzed the acylation of ADP to
broaden the knowledge concerning the structure of this
protein as a first step to gain insight into possible func-
tions and functional mechanisms of ADP. We have
shown that ADP is palmitoylated and, using vector ex-
pression of mutated ADP genes, we have identified two
cysteine residues directly adjacent to the cytoplasmic
tail boundary that are required for palmitoylation and
probably serve as acceptor sites.
RESULTS
ADP is labeled by radioactive palmitic acid
Inspection of the amino acid sequence of the different
versions of ADP in subgroup C adenoviruses revealed
the presence of two cysteine residues that are in a
sequence context favoring the assumption that ADP is
acylated by long chain fatty acids. They are located at the
boundary between transmembrane and cytoplasmic do-
main (Fig. 1). To investigate possible acylation of ADP,
Ad2- and Ad5-infected HeLa cells were metabolically
labeled with [35S]methionine/cysteine ([35S]-met/cys) or
[3H]palmitic acid. ADP was immunoprecipitated using a
polyclonal antiserum against a peptide derived from the
sequence of the Ad2 version of ADP. This antiserum
precipitates both Ad2- and Ad5-ADP (Fig. 2A) which both
belong to subgenus C. The sequence in the respective
peptide in Ad5-ADP differs in only two amino acids from
that of Ad2-ADP, and, moreover, in one of the two differ-
ing positions, a lysine instead of an arginine in a stretch
of basic amino acids is found in Ad5-ADP. This suggests
that the antigenic properties of the peptide in the two
proteins are very similar and explains the observed
cross-reactivity. In contrast, the ADP homologue of the
subgenus B serotype 3, which has lower sequence sim-
ilarity, is not precipitated by our polyclonal antiserum
(Fig. 2A), indicating that recognition of Ad5-ADP by the
polyclonal antiserum is specific. Immunoprecipitation of
[35S]-met/cys-labeled Ad5- and Ad2-ADP yields a spe-
FIG. 1. Schematic representation of wild-type and mutant ADP. (A) Numbers refer to amino acid positions in Ad5-ADP. Positions of the cysteine
residues at the boundary between transmembrane and cytoplasmic domain are depicted. (B) Amino acid sequences of wild-type and mutant Ad5-ADP
are shown around the mutated cysteine residues at the border between transmembrane and cytoplasmic region indicated by a vertical hatched line
together with the corresponding region in Ad2-ADP. Construction of mutants is described under Materials and Methods. The pair of mutated amino
acids are underlined. Please note also the cysteine at position 45 (Ad5) that does not seem to be acylated (see text).
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cific pattern of bands that is very similar between Ad2-
and Ad5-ADP (Fig. 2A). After steady state labeling three
main clusters of bands can always be distinguished,
which in the case of Ad2-ADP migrate at ca. 14, 21, and
25–30 kDa in SDS–PAGE as has been described previ-
ously (Tollefson et al., 1992). The respective bands of
Ad5-ADP migrate somewhat faster, which is in agree-
ment with the eight-amino-acids-shorter polypeptide
backbone of Ad5-ADP. Specificity of the immunoprecipi-
tation assay was confirmed by immunoprecipitation of a
labeled lysate from HeLa cells infected with H2dl801
(Challberg and Ketner, 1981), a mutant Ad2 virus that
lacks most of the E3 region including the ADP gene
(Wang et al., 1988). No ADP-specific pattern of bands
was obtained from either H2dl801-infected cells or mock-
infected cells (Fig. 2B). Upon prolonged labeling times of
6 to 8 h, a fourth band repeatedly occurred which was
generally weaker than the others and migrated at about
16–18 kDa (Figs. 3A and 3B).
Labeling with [3H]palmitic acid yielded all three major
bands demonstrating that Ad5-ADP is indeed acylated
(Fig. 3A, lane 2) as suggested by the presence of cys-
teine residues close to the C-terminal border of the
membrane anchor. Labeling of the fourth band of about
16–18 kDa was very weak but could be detected after
very long exposure times (data not shown). The incorpo-
FIG. 2. Immunoprecipitation of [35S]-labeled ADP of different Ad
strains. ADPs from different Ad strains were labeled with [35S]methi-
onine/cysteine and immunoprecipitated as described. Note that the
sharp band at about 27 kDa that was always coimmunoprecipitated
from Ad2 and Ad5-infected 35S-labeled HeLa cells is not specific for
ADP as it also appears after immunoprecipitation of H2dl801-infected
cells lacking the ADP ORF. This band migrates within the largest
species of Ad5-ADP. A and B are from different experiments. 14C,
molecular weight standard (Amersham).
FIG. 3. Labeling of ADP with [3H]palmitic and [3H]myristic acid and deacylation. (A) The first three lanes show labeling of Ad5-ADP with [3H]palmitic
acid, [3H]myristic acid, and [35S]methionine/cysteine. The gel was then subjected to hydroxylamine treatment and fluorographed and exposed a
second time (lanes 4–6). (B) Immunoprecipitated [3H]palmitic acid- and [35S-labeled ADP were treated with the indicated concentrations of
b-mercaptoethanol as described. The film was overexposed with respect to the lanes showing 35S-labeled ADP to obtain a sufficiently strong signal
of lanes showing [3H]palmitic acid-labeled ADP. (C) Immunoprecipitated 3H-label is ADP-specific. HeLa cells infected with Ad5 and H2dl801,
respectively, were labeled with [3H]palmitic acid and lysates were immunoprecipitated with ADP-specific polyclonal antiserum as described. 14C,
molecular weight standard (Amersham).
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ration of [3H]palmitic acid was weaker in Ad2-ADP than
in Ad5-ADP relative to the incorporated [35S]-met/cys,
suggesting that the efficiency of fatty acid acylation of
Ad2-ADP is lower than that of Ad5-ADP. Nevertheless,
labeling of at least two of the three major bands of
Ad2-ADP with [3H]palmitic acid could be detected (data
not shown).
Metabolic labeling of Ad5-infected cells with [3H]myr-
istic acid followed by immunoprecipitation with specific
ADP antiserum yielded no detectable bands (Fig. 3A),
strongly suggesting that the 16-carbon palmitic acid was
not shortened in intracellular metabolic pathways to the
14-carbon myristic acid prior to incorporation but was
rather attached to ADP as such. To verify that the bands
obtained after immunoprecipitation of [3H]palmitic acid-
labeled Ad5-infected HeLa cells indeed represent ADP,
HeLa cells infected with H2dl801 lacking the ADP gene
were labeled with [3H]palmitic acid. No [3H]palmitic acid-
labeled bands could be detected in H2dl801-infected
cells with the ADP-specific antiserum in contrast to those
from Ad5-infected cells (Fig. 3C).
In order to determine the nature of the fatty acid bond
in ADP, we treated the [3H]palmitic acid-labeled protein
with 1 M hydroxylamine in neutral pH. Hydroxylamine
cleaves off fatty acid bound by an ester-type linkage.
When the reaction is carried out around neutral pH,
especially thioester-type linkages are cleaved and can
thus be distinguished from amide bonds (Magee et al.,
1984). Hydroxylamine treatment completely removed all
incorporated [3H]palmitic acid labeling from Ad5-ADP
while not affecting the 35S-labeled ADP demonstrating
an ester-type linkage of the fatty acid (Fig. 3A, lanes 4–6).
Moreover, because the label was removed under neutral
conditions, a thioester bond is more likely than an oxyes-
ter bond. Incubation of [3H]palmitic acid-labeled proteins
with higher concentrations of b-mercaptoethanol allows
distinction between thioester and oxyester linkage be-
cause b-mercaptoethanol preferably hydrolyzes thio-
ester linkages (Schmidt et al., 1988; Arumugham et al.,
1989). Boiling of [3H]palmitic acid-labeled ADP in SDS–
PAGE sample buffer containing 2.5% b-mercaptoethanol
did not release fatty acids from ADP in significant
amounts (Fig. 3B). In contrast, boiling in 20% b-mercap-
toethanol completely liberated all incorporated label in-
dicative of a thioester linkage (Fig. 3B). The reason for
the slightly higher electrophoretic mobility of 35S-labeled
ADP-specific bands after treatment with 20% b-mercap-
toethanol compared to the sample treated with 2.5%
b-mercaptoethanol is not clear. It may be a consequence
of the missing fatty acids that have been shown to be
able to alter the electrophoretic mobility of proteins of
comparable size like the 6-K protein of Semliki Forest
virus or the influenza M2 protein (Gaedigk-Nitschko and
Schlesinger, 1990; Veit et al., 1991a), but may also indi-
cate that the 35S-labeled ADP has not been completely
reduced prior to SDS–PAGE. Taken together, palmitic
acid appears to be linked to cysteine residues in ADP,
probably at one or both of the cysteine residues directly
C-terminal to the transmembrane region of ADP.
Determination of the nature of the incorporated fatty
acid
To confirm the conclusions of the labeling experiments
with respect to the chemical nature of the attached fatty
acid, we performed a chemical analysis of the incorpo-
rated [3H]-label. For this purpose, the respective ADP-
specific bands from SDS–polyacrylamide gels were an-
alyzed by thin-layer chromatography (TLC). By compari-
son with 3H-labeled palmitic and myristic acid standard,
the 3H-labeled molecules released from ADP could be
identified as palmitic acid (Fig. 4). A very faint band
representing myristic acid can also be detected, but
palmitic acid clearly represents the vast majority of acyl
groups on ADP. Thus, no significant metabolic conver-
sion of palmitic acid into the shorter fatty acid myristic
acid [C 14:0] or the longer stearic acid [C 18:0] had
occurred before or after attachment to ADP as has been
described for a number of acylated proteins like the HEF
protein of influenza C (Reverey et al., 1996).
Analysis of the palmitoylation Site in Ad5-ADP
We next attempted to identify the site of palmitoylation
in ADP by exchanging the putative acceptor cysteines to
alanines by site-directed mutagenesis. We chose the
Ad5 version of ADP because labeling of Ad5-ADP with
[3H]palmitic acid was more effective than that of Ad2-
ADP. Acylation of viral membrane proteins has been
reported to occur mainly at the C-terminal end of the
transmembrane domain or proximal to it in the cytoplas-
mic domain at cysteine residues (Schmidt, 1989; Veit et
al., 1991b; Hensel et al., 1995). A frequently found but not
very well-defined sequence motif comprises an isoleu-
cine residue in direct N-terminal vicinity of the cys-
teine(s) serving as acceptor site(s) and one or more
FIG. 4. TLC analysis of ADP-bound fatty acids. A hydrolysate of
[3H]palmitic acid-labeled Ad5-ADP from gel slices representing the
uppermost ADP band was analyzed by TLC as described. The amount
of Ad5-ADP used for the analysis corresponds to 2 3 106 3H-labeled
HeLa cells. Starting point and migration direction of the fluorographed
TLC plate are indicated. 3H-labeled fatty acid standards are shown in
lanes 1 and 3.
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basic residues at the C-terminal side of the cysteines
(Ponimaskin and Schmidt, 1995). The two cysteine resi-
dues 53 and 54 at the border between transmembrane
region and cytoplasmic tail of Ad5-ADP satisfy these
criteria, they are also found in Ad2-ADP at positions 60
and 61. By site-directed mutagenesis of the Ad5-ADP
gene, we constructed three mutants in which cysteine 53
(mutant cysN), cysteine 54 (mutant cysC), or both cys-
teines (mutant cys2) are replaced by alanine residues.
The mutant ADP genes were cloned into expression
vector pTM1 under the control of the T7 promotor for use
with the vaccinia virus T7 expression system and also
into a transfer plasmid for the construction of recombi-
nant baculoviruses (pVL1392). Expression of wild-type
and mutant ADP in HeLa cells by the vaccinia virus T7
system revealed a different pattern of bands compared
to infection with ADP-containing Ad5 or Ad2. Only two
major bands of about 17 and 22 kDa occurred, which are
ADP-specific because they could not be detected in cells
transfected with a control plasmid (Fig. 5A). The same
pattern was observed upon expression of ADP in insect
cells by a recombinant baculovirus; however, the amount
of baculo-expressed ADP was very much lower than
expected (data not shown). The various mutant ADPs did
not exhibit different electrophoretic mobilities compared
to the wild type (Fig. 5A). Labeling with [3H]palmitic acid
revealed that vectorially expressed wild-type ADP as
well as the single cysteine substitution mutants have
incorporated palmitic acid. In contrast, the double cys-
teine mutant could not be labeled with [3H]palmitic acid,
indicating that this mutant can no longer be acylated by
palmitic acid (Fig. 5B). Thus, cysteines 53 and 54 are
required for palmitoylation of ADP, probably because
they represent palmitoylation acceptor sites, whereas a
third cysteine located in the transmembrane region 8
amino acids upstream of the proposed boundary be-
tween membrane anchor and cytoplasmic tail does not
serve as an acceptor site at least when the two cyto-
plasmic cysteine residues are missing. Wild-type ADP
was present in lower amounts as indicated by 35S-label-
ing, whereas the intensity of [3H]palmitic-labeled wild-
type bands was the same as that of the single cysteine
substitution mutants (Fig. 5). This can be interpreted in a
way that the relative amount of [3H]palmitic acid per
wild-type ADP molecule is higher than in the single
substitution mutants, suggesting that both cysteines of
one ADP molecule are palmitoylated in the wild type.
Upon prolonged exposure of the film, an additional ADP-
specific smear of higher molecular weight around 23–30
kDa can be detected in the 35S-labeled samples, which
corresponds to a very faint broader band of comparable
size in the samples of the vectorially expressed and
[3H]palmitic acid-labeled ADP samples. Baculovirus-ex-
pressed ADP could also be labeled with [3H]palmitic
acid, indicating that palmitoylation of expressed ADP
takes place in insect cells which provides an additional
system for analysis of ADP function and dissection of its
modifications.
Analysis of the single and double cysteine replace-
ment mutants demonstrated that, although the ex-
pressed wild type and mutant ADPs may differ in some
co- or posttranslational modifications from authentical
Ad5-ADP, vectorially expressed wild-type ADP is palmi-
toylated and that cysteines 53 and 54 both are required
for palmitoylation and probably serve as acceptor sites
for palmitic acid. Thus, while we cannot formally exclude
the possibility that the two cysteines represent a signal
for palmitoylation of the third cysteine at position 45 in
the transmembrane domain, the direct modification of
the two cytoplasmic cysteine residues by palmitic acid is
the most probable explanation which is consistent with
all other examples of palmitoylated viral membrane pro-
teins reported so far.
DISCUSSION
In the present communication we have shown that
ADP is modified by palmitic acid and that two cysteine
residues at the boundary between transmembrane re-
gion and cytoplasmic tail are essential for palmitoylation.
One necessary experiment was the expression of mu-
tated ADP which is described here for the first time
based on viral expression systems. The pattern of bands
obtained from the vectorially expressed ADP gene is
strikingly different from the wild-type situation, because
the abundant species with highest molecular weight
found in Ad-infected cells is present in only very small
FIG. 5. Incorporation of fatty acids into ADP mutants. Wild-type and
mutant ADP was expressed in HeLa cells by the vaccinia T7 system as
described. (A) Labeling of expressing HeLa cells and cells transfected
with the empty plasmid vector 17 h after infection for 4 h with [35S]me-
thionine/cysteine followed by immunoprecipitation and 16.5% SDS–
PAGE. (B) A parallel set of transfected HeLa cells was labeled with
[3H]palmitic acid for 4 h as described. 14C, molecular weight standard
(Amersham).
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amounts. Endoglycosidase digestion of vector-ex-
pressed ADP, which contains one potential N-glycosyla-
tion site, demonstrated that the upper band is indeed
N-glycosylated, but exclusively with a high-mannose oli-
gosaccharide (unpublished results). One possible expla-
nation is that vector-expressed ADP is not or only very
inefficiently transported beyond the medial Golgi. More-
over, only a small portion seems to reach the medial
Golgi. On the other hand, the expressed ADP apparently
is not simply retained in the ER, because palmitoylation
in the exocytotic pathway is thought to occur in a post-ER
pre-Golgi compartment (Schmidt and Schlesinger, 1980;
Bonatti et al., 1989; Veit and Schmidt, 1993) and the
expressed ADP can obviously be palmitoylated, indicat-
ing that it leaves the ER. Mutant ADP lacking palmitic
acid shows the same pattern as wild-type ADP, suggest-
ing that its transport is not influenced by palmitoylation
which is in accordance with earlier observations on
palmitoylation-deficient mutant proteins (Veit et al.,
1991b; Crise and Rose, 1992). Yet another interesting
notion is the fact that also the smallest ADP species is
palmitoylated (Fig. 3A), suggesting that it enters the exo-
cytotic pathway and is a membrane-bound species
present at least in ER and a post-ER compartment al-
though it seems to be unglycosylated (unpublished ob-
servation).
As for other palmitoylated viral proteins, the cysteines
in ADP modified by palmitic acid are well conserved
among all ADP homologues in subgenus C adenovi-
ruses. This has been confirmed by sequencing of the
ADP genes of type 1 and 6 Ads (unpublished results),
which also contain the cystein residues at the boundary
between transmembrane and cytoplasmic domain.
The functional significance of ADP palmitoylation is
still unclear, but with respect to characterized functions
of acylated proteins, at least two hypotheses can be
made. The first is based on the recent observation that
two cellular proteins interact in a manner dependent on
the palmitoylation status of one of these two proteins,
GAP-43 (Sudo et al., 1992). GAP-43 is a neuronal protein
that increases guanine nucleotide exchange by interact-
ing with G proteins that are palmitoylated as well as
myristoylated. It lacks a hydrophobic transmembrane
domain and is N-terminally palmitoylated at two cys-
teines, thus belonging to the second class of palmitoy-
lated proteins different from the type represented by viral
glycoproteins that are palmitoylated during passage
through the exocytotic pathway. It has been postulated
that regulation of protein–protein interactions by palmi-
toylation might be a general principle (Casey, 1995; Mil-
ligan et al., 1995) which makes it tempting to speculate
about protein–protein interaction between adenovirus
proteins E1B-19K and ADP. E1B-19K which does not
possess a transmembrane domain has been reported to
be acylated by myristic as well as palmitic acid (Mc-
Glade et al., 1987), although not at cysteine residues, and
is localized at ER membranes and the nuclear envelope
(White et al., 1984). Possibly, ADP interacts with E1B-19K
depending on the palmitoylation status late in infection
suppressing the anti-apoptotic activity of E1B-19K. Re-
lease of the E1B-mediated block in apoptosis may at
least represent a first step in the mechanism of ADP-
induced cell death. Interaction between integral and pe-
ripheral membrane proteins of viruses has also been
proposed to be influenced by palmitoylation (Ivanova and
Schlesinger, 1993). It should also be noted that unlike in
the GAP43/G protein model there is no evidence so far
for a reversible type of acylation of either E1B-19K or
ADP. As a second possibility, palmitoylation of two pro-
teins that putatively interact might be of significance
because it could direct these proteins into the same
areas of cellular membranes with a distinct lipid compo-
sition instead of directly mediating interaction. Associa-
tion of proteins with specific membrane microdomains
has been shown, for example, for the palmitoylated in-
fluenza virus HA which preferably localizes to sphingo-
lipid- and cholesterol-enriched areas of cellular mem-
branes (Skibbens et al., 1989) which has consequences
for its intracellular transport and localization (Simons and
Ikonen, 1997). It might be speculated that palmitoylation
of ADP could direct this protein into specialized mem-
brane microdomains where the fatty acid-anchored E1B-
19K is also enriched, thereby facilitating interaction of
these two proteins.
Analysis of the structural features of ADP leads to the
second hypothesis concerning function of ADP and the
putative role of palmitoylation therein. Structurally, ADP
seems to be more closely related to the palmitoylated
membrane proteins of RNA viruses. In contrast to other
acylated viral membrane proteins which play a role in
virus assembly and release and are components of the
virion particle, the membrane protein ADP is certainly not
incorporated into nonenveloped adenovirus particles.
Nevertheless the structural properties of ADP suggest
that it might belong to a postulated class of functionally
and structurally related proteins termed viroporines
(Carrasco, 1995). These proteins have several features in
common including their relatively small size, hydropho-
bic transmembrane domain, regions of basic amino ac-
ids, glycosylation, and namely acylation. All these fea-
tures have been shown for the M2 protein of influenza A
viruses and the 6K protein of Semliki Forest virus. For 1A
protein of RSV, palmitoylation has not been reported so
far. Their function of mediating release of viral progeny is
accomplished by forming hydrophilic pores in the mem-
brane allowing passage of small ions or other small
molecules. So far, a pore function has only been dem-
onstrated for influenza M2 protein (Pinto et al., 1992). In
the case of small-sized proteins, a prerequisite for this
feature is the formation of oligomers, which have been
demonstrated for a number of proposed viroporins. Al-
though we attempted to show this for ADP by chemical
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cross-linking, we were not able to detect oligomeric
structures so far (data not shown). Further experiments
are needed for detection of oligomerization of ADP as
well as to prove the modification of membrane perme-
ability by ADP. A hint for the latter might be the observa-
tion that the complete ADP molecule including the trans-
membrane domain has been impossible to express in
Escherichia coli, whereas without the hydrophobic trans-
membrane domain, expression of this mutant ADP in E.
coli was very effective (data not shown), suggesting a
toxic effect of wild-type ADP. Thus, procaryotic expres-
sion, as has been suggested for determination of func-
tional features of viroporins in general (Carrasco, 1995)
might provide a tool for verifying membrane-modifying
activity of ADP.
Although palmitoylation has long been shown for sev-
eral gene products encoded by DNA viruses, ADP is the
first to be characterized with respect to its exact acyla-
tion site. Moreover, to our knowledge, ADP is also the
first membrane-spanning glycoprotein transported to the
nuclear envelope that is palmitoylated. Genetic manipu-
lation of adenoviruses is a well-established technique.
Thus, while at this experimental stage we cannot define
a role for ADP palmitoylation in either its function or its
intracellular distribution, further experiments with genet-
ically modified adenovirus expressing nonpalmitoylated
ADP promise to reveal the significance of ADP palmitoyl-
ation and provide further insight into the mechanism of
ADP function.
MATERIALS AND METHODS
Viruses and cell lines
Adenoviruses types 2 and 5 were propagated on HeLa
cells. Titration was performed by a fluorescence-based
focus-forming assay on HeLa cells and by plaquing on
E293 cells obtained from Microbix (Canada). HeLa cells
were maintained in Dulbecco’s modified MEM (DMEM)
containing 10% fetal calf serum (FCS, Life Technologies);
E293 cells were cultured in MEM in Earle’s salt contain-
ing 10% FCS (Life Technologies). H2dl801 in which all E3
open reading frames (ORFs) were deleted except the
12.5-K and 14.7-K ORFs (Challberg and Ketner, 1981;
Wang et al., 1988) were obtained from Dr. M. Burgert
(Freiburg, Germany). The recombinant vaccinia virus
vTF7-3 (Fuerst et al., 1986) was provided by Prof. H.-D.
Klenk (Marburg, Germany), and was grown in CV1 cells
maintained in DMEM supplemented with 5% FCS and
titered by plaquing on HeLa cells.
Plasmids, constructs, and mutagenesis
The coding sequence for the Ad5-ADP (ORF) includ-
ing three nucleotides upstream of the start codon was
amplified by PCR using 100 ng of purified Ad5-DNA as
template and the following primers containing a PstI
recognition site in the sense primer (a) and an EcoRI
site in the antisense primer (b): (a) 59-ATC TGC AGG
AGA TGA CCA ACA CAA CCA ACG CG-39; (b) 59-GTG
AAT TCT CAT ACT GTA AGA GAA AAG AAC ATG-39.
The resulting PCR product was digested with restric-
tion enzymes EcoRI and PstI and ligated into the EcoRI
and PstI sites of plasmid pUC19 (Boehringer-Mann-
heim, Germany). The identity of the Ad5-ADP clone
was verified by sequencing of the complete cloned
ORF. The ADP gene was subcloned into the baculovi-
rus transfer vector pVL1392 via PstI and EcoRI restric-
tion sites. For in vitro mutagenesis, the ADP-ORF was
subcloned in M13mp19 using PstI and EcoRI and mu-
tations were introduced by the phosphorothioate
method using a commercially available kit (Amersham,
Braunschweig, Germany). The CUG codons 53 and 54
coding for cysteines were mutated to CCG coding for
alanines singly or in combination. Primers used were
59-GCG CTT TAG GCA GGC GAT GAG CCA CAT AA-39
for cys 53 (mutant cysN), 59-GTT TGC GCT TTA GGG
CGC AGA TGA GCC AC-39 for cys 54 (mutant cysC),
and 59-GTT TGC GCT TTA GGG CGG CGA TGA GCC
ACA TAA T-39 for cys 53/cys 54 (mutant cys2). Mutated
ADP-ORFs were amplified by PCR with primers creat-
ing NcoI at the 59-end and EcoRI at the 39-end refer-
ring to the sense strand. The digested PCR products
were subcloned into the NcoI and EcoRI restriction
sites of the plasmid transfer vector pTM1 (Moss et al.,
1990) under the control of the T7 promotor. The result-
ing plasmids were designated pTM1-CysN (cys 53 to
ala), pTM1-CysC (cys 54 to ala), and pTM1-Cys2 (cys-
teines 53 and 54 to alanines). All mutations and the
entire ORFs of the respective mutants as well as the
wild-type sequence were reconfirmed by dideoxyse-
quencing of the pTM constructs.
Transient expression of ADP
To analyze the acylation status of the cysteine mu-
tants, the respective mutated genes were transiently
expressed in HeLa cells using the vaccinia T7 expres-
sion system (Fuerst et al., 1986). HeLa cells were in-
fected at a m.o.i. of 5–7 with vTF7-3, a recombinant
vaccinia virus expressing T7 RNA polymerase. Fifty-mil-
limeter dishes were used for 35S-labeling and 100-mm
dishes were used for labeling with [3H]palmitic acid.
Virus inoculum was removed after 2 h, replaced with 3
and 10 ml of serum-free OptiMEM medium (Life Technol-
ogies) and transfection mixture was added dropwise and
distributed thoroughly. Transfection mixture contained 4
mg pTM1-ADP plasmids and 15 ml Lipofectin (Life Tech-
nologies) in 300 ml OptiMEM for 100-mm dishes, respec-
tively. Cells were incubated for a further 17 h and labeled
with [35S]methionine/cysteine and [35H]palmitic acid as
described below.
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Metabolic labeling and immunoprecipitation
About 106 HeLa cells infected with the respective ad-
enoviruses at a m.o.i. of 20 to 50 were labeled 26 h p.i.
with 130 mCi/ml of [35S]methionine and [35S]cysteine
(ProMix, Amersham) for 5 h followed by lysis in RIPA
buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS, 0.15 M NaCl, 20 mM Tris–HCl, pH 7.8; 10 mM EDTA,
25 mg/ml aprotinin, 1 mM PMSF, 10 mM iodoacetamide).
For analysis of ADP acylation, 5 3 106 HeLa cells in-
fected with the respective adenoviruses at a m.o.i. of 20
to 50 were labeled with 0.5mCi/ml [9,10-3H]palmitic acid
(Hartmann, Braunschweig, Germany) or [9,10-3H]myristic
acid (Amersham) from 26 to 32 h after infection. HeLa
cells transiently expressing ADP by vaccinia T7 expres-
sion vectors were either labeled with [35S]methionine/
cysteine-mix (Hartmann). (1 3 106 cells) or with 0.33
mCi/ml [9,10-3H]palmitic acid (5 3 106 cells). At the end of
the labeling period cells were then lysed in RIPA buffer
as described above. All lysates were cleared by centrif-
ugation for 20 min at 17,000 g and 4°C and then sub-
jected to preclearing with protein A–Sepharose and a
1:200 dilution of rabbit preimmune serum corresponding
to the ADP-specific antiserum. ADP was then immuno-
precipitated from the supernatants using polyclonal rab-
bit antiserum directed against a 15 aa peptide derived
from the Ad2-ADP primary sequence (aa63-77) in a 1:100
dilution. Immune complexes were recovered with protein
A–Sepharose CL-4B (Sigma). Following overnight incu-
bation, protein A–Sepharose-bound immune complexes
were washed three times with lysis buffer prior to disso-
ciation in SDS sample buffer. Immunoprecipitates were
separated on 16.5% SDS–polyacrylamide gels followed
by fixation and fluorography of the gels with Enlightning
(DuPont, Bad Homburg, Germany). For analysis of acy-
lated proteins, samples were run under nonreducing
conditions, whereas 35S-labeled proteins were sepa-
rated under reducing conditions.
Thin-layer chromatography
Analysis of fatty acids linked to ADP was done by
TLC as described previously (Veit et al., 1996). Briefly,
[3H]fatty acid-labeled and immunoprecipitated ADP
was separated on 16.5% SDS–polyacrylamide gels fol-
lowed by fluorography with 1 M salicylate (pH 7.5).
[3H]fatty acids were liberated and extracted from gel
slices containing the largest of the three major ADP
bands by acid hydrolysis and hexane extraction.
[3H]fatty acids were then analyzed by TLC on RP-18
plates (Merck, Mannheim, Germany) with acetonitrile/
acetic acid (1:1) as solvent system and visualized by
fluorography. As standards, radiolabeled reference
fatty acids [3H]palmitic acid and [3H]myristic acid were
run on the same plate.
Deacylation
Sensitivity of 3H-labeled ADP to hydroxylamine treat-
ment was analyzed by separation of 3H-labeled and
35S-labeled ADP samples on 16.5% SDS–polyacrylamide
gels. The gel was fluorographed as described and after
exposition to X-ray film, the gel was rehydrated and
immersed in 1 M hydroxylamine, pH 7.0, overnight, fol-
lowed by a second round of fluorography and exposition
to X-ray film for the same period of time as the first
exposition.
For deacylation by b-mercaptoethanol, immunopre-
cipitated ADP bound to protein A–Sepharose was di-
vided into two aliquots after the third wash step and the
two aliquots were incubated with 2.5% and 20% of b-mer-
captoethanol in SDS sample buffer and heated for 5 min
to 95°C. The protein A–Sepharose was then pelleted and
protein samples were subjected to SDS–PAGE.
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